Evidence map›Paper›PMID 33911042›Full record

ArticleJournal of the Korean Association of Oral and Maxillofacial Surgeons2021

A critical assessment of the medication-related osteonecrosis of the jaw classification in stage I patients: a retrospective analysis.

Oliver Ristow, Lena Hürtgen, Julius Moratin, Maximilian Smielowski, Christian Freudlsperger, Michael Engel, Jürgen Hoffmann, Thomas Rückschloß

Open access · diamondAbstract read
In one paragraph

Article in Journal of the Korean Association of Oral and Maxillofacial Surgeons, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Oliver RistowDepartment of Oral and Maxillofacial Surgery, University of Heidelberg, Heidelberg, Germany.ORCID https://orcid.org/0000-0002-3911-262X
Lena HürtgenDepartment of Oral and Maxillofacial Surgery, University of Heidelberg, Heidelberg, Germany.ORCID https://orcid.org/0000-0002-0965-3660
Julius MoratinDepartment of Oral and Maxillofacial Surgery, University of Heidelberg, Heidelberg, Germany.ORCID https://orcid.org/0000-0002-0278-7228
Maximilian SmielowskiDepartment of Oral and Maxillofacial Surgery, University of Heidelberg, Heidelberg, Germany.ORCID https://orcid.org/0000-0002-4293-3541
Christian FreudlspergerDepartment of Oral and Maxillofacial Surgery, University of Heidelberg, Heidelberg, Germany.ORCID https://orcid.org/0000-0002-4289-0457
Michael EngelDepartment of Oral and Maxillofacial Surgery, University of Heidelberg, Heidelberg, Germany.ORCID https://orcid.org/0000-0001-8573-0464
Jürgen HoffmannDepartment of Oral and Maxillofacial Surgery, University of Heidelberg, Heidelberg, Germany.ORCID https://orcid.org/0000-0002-3286-2145
Thomas RückschloßDepartment of Oral and Maxillofacial Surgery, University of Heidelberg, Heidelberg, Germany.ORCID https://orcid.org/0000-0002-7955-9194
Heidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesIt is unclear whether the extent of intraoral mucosa defects in patients with medication-related osteonecrosis of the jaw indicates disease severity. Therefore, this study investigated whether mucosal lesions correlate with the true extent of osseous defects in stage I patients. MATERIALS AND

methodsRetrospectively, all patients with stage I medication-related osteonecrosis of the jaw who underwent surgical treatment between April 2018 and April 2019 were enrolled. Preoperatively, the extent of their mucosal lesions was measured in clinical evaluations, and patients were assigned to either the visible or the probeable bone group. Intraoperatively, the extent of necrosis was measured manually and with fluorescence.

resultsFifty-five patients (36 female, 19 male) with 86 lesions (46 visible bone, 40 probeable bone) were enrolled. Intraoperatively, the necrotic le-sions were significantly larger (

conclusionPreoperative mucosal defects (visible or probeable) in patients with medication-related osteonecrosis of the jaw do not indicate the extent of bone necrosis or disease severity.

Indexed as

Antiresorptiva-related osteonecrosis of the jawBisphosphonate-related osteonecrosis of the jawClassificationDefinitionMedication-related osteonecrosis of the jaw

Identifiers

PMID33911042
PMCPMC8084747
OpenAlexW3159859005

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.